UNI-EN 33:Unaudited Interim Financial Report of the Krka Group and Krka Company for H1 2024
Firma: KRKA, TOVARNA ZDRAVIL D.D.Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
-
Unaudited Interim Financial Report of the Krka Group and Krka Company for 1H 2024.pdfUnaudited Interim Financial Report of the Krka Group and Krka Company for H1 2024
-
Press Release.pdfPress Release
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|
| UNI - EN REPORT No | 33 | / | 2024 | |||||||
| Date of issue: | 2024-07-18 | ||||||||||
| Short name of the issuer | |||||||||||
| KRKA | |||||||||||
| Subject | |||||||||||
| Unaudited Interim Financial Report of the Krka Group and Krka Company for H1 2024 | |||||||||||
| Official market - legal basis | |||||||||||
| art. 17. 1 MAR. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Based on Article 26 of the Rules of the Ljubljana Stock Exchange, d. d., Ljubljana and Article 136 of the Market in Financial Instruments Act, Krka, d. d., Novo mesto publishes the Unaudited Interim Financial Report of the Krka Group and Krka, d. d., Novo mesto for the six months ended 30 June 2024. The report will be published on the Company's website (www.krka.biz) from 18 July 2024 onwards, for a period of at least 10 years. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Unaudited Interim Financial Report of the Krka Group and Krka Company for 1H 2024.pdf Unaudited Interim Financial Report of the Krka Group and Krka Company for 1H 2024.pdf | Unaudited Interim Financial Report of the Krka Group and Krka Company for H1 2024 | ||||||||||
| Press Release.pdf Press Release.pdf | Press Release | ||||||||||
| KRKA, TOVARNA ZDRAVIL D.D. | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| KRKA | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 8501 | Nove Mesto | ||||||||||||
| (post code) | (city) | ||||||||||||
| Smarjeska | 6 | ||||||||||||
| (street) | (number) | ||||||||||||
| +386 7 331 21 11 | +386 7 332 15 37 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nie dotyczy | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2024-07-18 | Jože Colarič | President of the Management Board and CEO | |||
Cena akcji Krka, tovarna zdravil, d.d., Novo mesto
Cena akcji Krka, tovarna zdravil, d.d., Novo mesto w momencie publikacji komunikatu to 636.0 PLN. Sprawdź ile kosztuje akcja Krka, tovarna zdravil, d.d., Novo mesto aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Krka, tovarna zdravil, d.d., Novo mesto.
